Sign Up to like & get
recommendations!
0
Published in 2021 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2021.102981
Abstract: BACKGROUND Anti-CD20 monoclonal antibodies (mAb) have demonstrated their drastic efficacy in the treatment of active relapsing-remitting multiple sclerosis (RR-MS). This study investigates the management of their initiation after another disease modifying therapy (DMT). The objective…
read more here.
Keywords:
monoclonal antibodies;
switching towards;
cd20 monoclonal;
study ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "British Journal of Haematology"
DOI: 10.1111/bjh.14534
Abstract: This phase 1/2 study evaluated the safety, pharmacokinetic behavior and anti‐tumour activity of ublituximab, a unique type I, chimeric, glycoengineered anti‐CD20 monoclonal antibody, in rituximab‐relapsed or ‐refractory patients with B‐cell non‐Hodgkin lymphoma (B‐NHL) or chronic…
read more here.
Keywords:
cell non;
anti cd20;
cd20 monoclonal;
non hodgkin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.27_suppl.261
Abstract: 261 Background: The US Food and Drug Administration has issued a boxed warning for anti-CD20 monoclonal anti-bodies for the reactivation of Hepatitis B virus (HBV) infection. The National Comprehensive Cancer Network (NCCN) Non-Hodgkin Lymphoma and…
read more here.
Keywords:
cd20 monoclonal;
antibody;
compliance;
anti cd20 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.805697
Abstract: Nephrotic proteinuria is the hallmark of several glomerulonephritis determined by different pathogenetic mechanisms, including autoimmune, degenerative and inflammatory. Some conditions such as Minimal Change Nephropathy (MCN) and Focal Segmental Glomerulosclerosis (FSGS) are of uncertain pathogenesis.…
read more here.
Keywords:
different proteinuric;
cd20 monoclonal;
anti cd20;
nephrotic syndrome ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15041109
Abstract: Simple Summary CD20 monoclonal antibodies exert a strong ability to quickly kill B cells by using different mechanisms, both direct and indirect, and assessment of killing is difficult. Cytometry emerged as an attractive alternative to…
read more here.
Keywords:
cell death;
cell;
rtx;
direct killing ... See more keywords